These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28140402)

  • 41. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
    Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D
    Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss.
    Tracy TE; Sohn PD; Minami SS; Wang C; Min SW; Li Y; Zhou Y; Le D; Lo I; Ponnusamy R; Cong X; Schilling B; Ellerby LM; Huganir RL; Gan L
    Neuron; 2016 Apr; 90(2):245-60. PubMed ID: 27041503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.
    McKenzie-Nickson S; Chan J; Perez K; Hung LW; Cheng L; Sedjahtera A; Gunawan L; Adlard PA; Hayne DJ; McInnes LE; Donnelly PS; Finkelstein DI; Hill AF; Barnham KJ
    ACS Chem Neurosci; 2018 Nov; 9(11):2731-2740. PubMed ID: 29920069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
    Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
    Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
    Xia L; Pang Y; Li J; Wu B; Du Y; Chen Y; Luo M; Wang Y; Dong Z
    J Alzheimers Dis; 2021; 84(1):239-248. PubMed ID: 34511503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles.
    Di Meco A; Joshi YB; Praticò D
    Neurobiol Aging; 2014 Aug; 35(8):1813-20. PubMed ID: 24629673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
    Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
    Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss.
    Kauwe G; Pareja-Navarro KA; Yao L; Chen JH; Wong I; Saloner R; Cifuentes H; Nana AL; Shah S; Li Y; Le D; Spina S; Grinberg LT; Seeley WW; Kramer JH; Sacktor TC; Schilling B; Gan L; Casaletto KB; Tracy TE
    J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38299587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride.
    Mietelska-Porowska A; Gasiorowska A; Palasz E; Koss DJ; Riedel G; Niewiadomska G
    J Neurosci Methods; 2019 May; 319():47-59. PubMed ID: 30448465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.
    Domise M; Didier S; Marinangeli C; Zhao H; Chandakkar P; Buée L; Viollet B; Davies P; Marambaud P; Vingtdeux V
    Sci Rep; 2016 May; 6():26758. PubMed ID: 27230293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation.
    Akwa Y; Gondard E; Mann A; Capetillo-Zarate E; Alberdi E; Matute C; Marty S; Vaccari T; Lozano AM; Baulieu EE; Tampellini D
    Mol Psychiatry; 2018 Jun; 23(6):1530-1540. PubMed ID: 28696431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.